# Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

> **NCT06086496** · — · ENROLLING_BY_INVITATION · sponsor: **Genoss Co., Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** GENOSS® DES Sirolimus Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT06086496
- **Lead sponsor:** Genoss Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-07-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06086496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06086496, "Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06086496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*